May 2, 2007 – OTN, a physician services company and Oncology Molecular imaging, LLC (OMI), an oncology-focused ancillary services company, recently announced that they have entered into an exclusive strategic alliance agreement where OTN will provide its customers with information and access to OMI's radiation therapy and diagnostic imaging services.
OMI offers a comprehensive solution that includes feasibility analysis, equipment selection, financing and capitalization of equipment, installation, maintenance, licensure and certifications and ongoing education to physicians and staff on clinical integration and treatment guidelines. The clinical integration of diagnostic imaging services with cancer treatment reportedly results in improved quality of care due to optimal scheduling of tests and faster turn-around time on results.
OTN also has made an undisclosed investment in OMI's business.
June 28, 2024 
